AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Machine Perception Picodya | Re-Innovating Point of Care Diagnostics

Enterprise, Biochemical Diagnostics, Health Diagnostics, Medical Devices Rehovot, HaMerkaz, Israel

Artificial Intelligence | Machine Learning | Machine Perception

Picodya | Re-Innovating Point of Care Diagnostics

Biochemical Diagnostics, Health Diagnostics, Medical Devices

Rehovot, HaMerkaz, Israel

Picodya introduces game-changing technology with the proven potential to empower wider diagnostics access around the globe.

After introducing drip irrigation technology 50 years ago and letting the world “grow more with less,” today we are presenting a new made-in-Israel innovation that will let the world “diagnose more with less” and pave the way to a healthier planet. Our in vitro diagnostics (IVD) platform is suitable for mass deployment at the point of care, from ICUs and hospital departments to field hospitals, clinics, and home care uses. By reducing the cost per test by orders of magnitude, we aim to make diagnostics tests accessible to everyone – anywhere, anytime.